371 related articles for article (PubMed ID: 17401592)
1. Economic aspects of the new Spanish laws on pharmaceutical preparations.
Antoñanzas F; Oliva J; Pinillos M; Juàrez C
Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
[TBL] [Abstract][Full Text] [Related]
2. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
3. Increasing generic drug use in Medicare Part D: the role of government.
Kohl H; Shrank WH
J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
[No Abstract] [Full Text] [Related]
4. Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
Kucukarslan S; Hakim Z; Sullivan D; Taylor S; Grauer D; Haugtvedt C; Zgarrick D
Clin Ther; 1993; 15(4):726-38. PubMed ID: 8221823
[TBL] [Abstract][Full Text] [Related]
5. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical policies in Canada: another example of federal-provincial discord.
Anis AH
CMAJ; 2000 Feb; 162(4):523-6. PubMed ID: 10701389
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
[No Abstract] [Full Text] [Related]
8. [Generic medicines].
Peláez de Loño J
Rev Enferm; 1999 Dec; 22(12):836-43. PubMed ID: 10797771
[TBL] [Abstract][Full Text] [Related]
9. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
Davidova J; Praznovcova L; Lundborg CS
Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
[TBL] [Abstract][Full Text] [Related]
10. A political economy perspective: why pharmacists may be reluctant to dispense generic medications.
Pelton LE; Strutton D; Smith MC
J Hosp Mark; 1994; 9(1):137. PubMed ID: 10142135
[TBL] [Abstract][Full Text] [Related]
11. The impact of reference-pricing systems in Europe: a literature review and case studies.
Dylst P; Vulto A; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):729-37. PubMed ID: 22098289
[TBL] [Abstract][Full Text] [Related]
12. New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition.
Antoñanzas F; Gómez P
Pharmacoeconomics; 2010; 28(11):977-80. PubMed ID: 20936881
[No Abstract] [Full Text] [Related]
13. Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance.
Yang BM; Bae EY; Kim J
Health Aff (Millwood); 2008; 27(1):179-87. PubMed ID: 18180493
[TBL] [Abstract][Full Text] [Related]
14. Generics market in Greece: the pharmaceutical industry's beliefs.
Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
[TBL] [Abstract][Full Text] [Related]
15. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
Gitlin M; Wilson L
Am J Ind Med; 2007 Apr; 50(4):303-15. PubMed ID: 17370319
[TBL] [Abstract][Full Text] [Related]
16. Incentives and pharmaceutical reimbursement reforms in Spain.
Puig-Junoy J
Health Policy; 2004 Feb; 67(2):149-65. PubMed ID: 14720633
[TBL] [Abstract][Full Text] [Related]
17. International prices and availability of pharmaceuticals in 2005.
Danzon PM; Furukawa MF
Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
[TBL] [Abstract][Full Text] [Related]
18. RX for nosebleed prices.
Greenwald J
Time; 2001 May; 157(20):42-3. PubMed ID: 11383109
[No Abstract] [Full Text] [Related]
19. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
Alván G
Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
[No Abstract] [Full Text] [Related]
20. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
Rai AK
Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
